Question Bank › Still getting better as they speak

Still getting better as they speak

Still getting better as they speak: strength that has continued or built past the reported period, tied to named live dr

Calls Tested
487
Answered YES
106
Hit Rate
21.8%
rare by design

IPG Photonics Corporation (IPGP) — this company's answers

NO on the Q3 2021 call 2021-11-02 C
The model's full reasoning — Q3 2021 call → NO我们根据提供的财报电话会议记录,判断管理层是否传达了业务积极势头在报告期后仍在延续,并且是否将这种延续与一个已命名的、正在运作的业务驱动因素联系起来。 首先,检查是否有迹象表明业务强度延续到报告期之后。管理层在电话中多次提到强劲的需求和订单增长。例如,Tim Mammen提到“第三季度订单出货比保持在1以上”(book-to-bill remained above 1),这表明订单水平超过了出货量,暗示未来季度有订单积压。此外,Eugene Scherbakov提到“我们看到北美和欧洲的IPG需求持续改善”(demand for IPG always are continuing to improve in North America and Europe)。Tim Mammen还提到“我们对明年的整体前景非常乐观”(we remain really quite optimistic about next year),并列举了增长驱动因素。然而,我们需要区分管理层是否将这种乐观仅作为预测,还是描述了已经观察到的活动。在回答中,Tim Mammen说:“在第三季度,除切割外的业务都非常强劲……我们实际上非常高兴,我们在添加剂应用中也获得了一些强劲的需求。”这似乎是在描述报告期内的表现。关于报告期后的活动,有提到“我们已经在第四季度又回购了约13.5万股”(have bought approximately another 135 thousand shares so far in the fourth quarter),但这不是业务活动。 关键是否有关于订单或销售在报告期后依然强劲的具体表述?Tim Mammen提到“第三季度订单出货比保持在1以上”,这通常意味着订货量超过出货量,暗示当前季度订单积压,但这是否意味着“持续到报告期后”有明确表述?管理层没有明确说“第四季度开始以来订单依然强劲”,但订单出货比大于1通常被视为前瞻性指标。不过,在电话会议中,他们给出了第四季度收入指引为3.3亿至3.6亿美元,相比第三季度3.79亿美元有所下降。这暗示第四季度收入可能低于第三季度(虽然指引下限和上限都低于第三季度实际)。因此,管理层并没有说第四季度会继续增长,而是预期下降(由于中国疲软)。在问答环节,当被问及2022年时,Tim Mammen说:“我们不会对明年的双位数增长发表评论……总体而言,我们对明年仍然非常乐观。”但这是关于明年的预测,而非已观察到的活动。 关于“延续”部分,是否有管理层的直接陈述表明在报告期后,业务活动依然强劲?例如,Eugene Scherbakov在开头说:“我们很高兴交付了本季度指引顶端的收入和每股收益。”后来,在讨论需求时,他说:“对IPG的需求在北美和欧洲持续改善。”但这是当前时点(电话会议时)的描述,可能指的是报告期内的趋势。然而,在问答中,有分析师问及第四季度及未来,管理层没有明确说“订单仍在涌入”或“销售在第四季度开始时依然强劲”。他们提到了“订单出货比高于1”和“需求回升”,但整体语气是积极的,但也承认第三季度业绩好于指引,但第四季度指引较低。 再查看“命名驱动因素”部分。管理层提到了多个具体驱动因素,例如“电动汽车电池生产”(EV battery manufacturing)、“LightWELD产品”、“医疗产品”、“超紧凑激光器”等。在回答延续性问题时,管理层的积极情绪是否与这些具体驱动器相关?在Tim Mammen的评论中,他列举了增长驱动因素:“电动汽车电池制造、电动汽车电机生产、白车身应用、新产品的推出,如LightWELD、医疗应用的增长、高功率切割市场向更高功率过渡等。”但这些都是针对明年的展望,而非已观察到的活动。 然而,关于“订单出货比高于1”是一个实际观察到的指标,表明当前订单积压,但这不是一个具体的驱动器。管理层是否将延续性直接归因于某个特定驱动器?在问答中,当被问及LightWELD时,Eugene Scherbakov说:“我们介绍了新的选项……我们乐观。”但这是关于未来的。 因此,我认为管理层没有明确传达业务强度在报告期后仍在继续,因为第四季度指引低于第三季度,而且他们提到中国走软。管理层虽然描述了对未来的乐观,但那是基于预测和机会,而非已观察到的活动。他们提到“订单出货比高于1”,但这可能只是当前季度的指标,并未明确说“进入第四季度订单依然强劲”。此外,他们明确说“第四季度中国销售将环比下降”(sales in China will be down sequentially in the fourth quarter)。因此,整体势头在报告期后并没有继续增强,反而可能在减弱。 所以答案应为NO。 但为了全面,我们确认是否有任何表述表明报告期后的强劲。在开篇,Eugene Scherbakov说:“我们很高兴交付了第三季度营收和每股收益的指引顶端。”这仅关于本季度。在Tim Mammen的评论中,他说:“第三季度订单出货比保持在1以上。”但随后他讨论的是第四季度展望,预期收入下降。因此,没有明确表述说活动延续。 因此,答案NO。

← Back to the full IPGP analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that the business's positive momentum HAS CONTINUED OR STRENGTHENED BEYOND THE PERIOD BEING REPORTED — that the improvement did not stop when the quarter closed, but is still running at the time management is speaking — AND does management tie that continuing strength to at least one NAMED, ALREADY-LIVE driver of the business rather than to hopes about conditions? Answer YES when management's own words convey BOTH halves of this one phenomenon, in whatever form fits the business: (1) STRENGTH THAT EXTENDS PAST THE REPORTED PERIOD. Management describes real business activity — such as orders, sales, bookings, customers, volumes, traffic, utilization, output, or wins — as having remained strong or gotten stronger in the latter part of the reported period AND/OR in the weeks since it ended, so that the pace at which the business is running NOW is at or above the level the reported results show. Any genuine expression of this counts, for example: momentum described as continuing or accelerating into the current quarter; activity since period-end described as strong, building, or ahead of the reported pace; trends that strengthened as the period progressed and are described as still in place; or management stating that what drove the quarter is still happening as they speak. The continuation must be presented as something already observed in actual business activity — not merely as guidance, a forecast, or general confidence about the year. (2) A NAMED, LIVE DRIVER BEHIND IT. When management explains why the strength is continuing, it points to at least one specific, identifiable driver that already exists and is already producing — such as a particular product, service, offering, customer or customer group, contract or program, market, channel, capability, or capacity that is currently generating the activity — rather than resting the continuation on hoped-for market recovery, seasonality, macro improvement, or generic optimism. The driver may take whatever form fits the industry; what matters is that management can say, in concrete terms, what is producing the ongoing strength and that it is in motion now. Answer NO if the reported period is weak, mixed, or merely stabilizing, so there is no strength to continue. NO if management describes the strong period but says nothing about activity continuing at or above that pace beyond it — a good quarter with only routine guidance is not this phenomenon. NO if the continuation is expressed only through forecasts, targets, pipeline, or hoped-for conditions rather than through observed activity. NO if management itself attributes the strength mainly to a one-time event, catch-up, pull-forward, easy comparison, or temporary condition it expects to fade, or describes momentum as slowing or normalizing. NO if the continuing strength is asserted only in generic terms ("momentum remains strong") with no identifiable live driver behind it anywhere on the call. NO if the continuation appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
WRBY Warby Parker Inc. Q1 2024 2024-05-09 A
AZEK The AZEK Company Inc. Q2 2024 2024-05-08 B+
CTRA Coterra Energy Inc. Q1 2024 2024-05-03 A
PPC Pilgrim's Pride Corporation Q1 2024 2024-05-03 A
CW Curtiss-Wright Corporation Q1 2024 2024-05-02 B+
ROCK Gibraltar Industries, Inc. Q1 2024 2024-05-01 B+
PDS Precision Drilling Corporation Q1 2024 2024-04-25 B
ASM Avino Silver & Gold Mines Ltd. Q4 2023 2024-03-21 C+
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
MNKD MannKind Corporation Q4 2023 2024-02-27 C
NICE NICE Ltd. Q4 2023 2024-02-22 B+
MET MetLife, Inc. Q4 2023 2024-02-01 B+
HP Helmerich & Payne, Inc. Q1 2024 2024-01-30 C
EMKR EMCORE Corporation Q4 2023 2023-12-12 C+
BRBR BellRing Brands, Inc. Q4 2023 2023-11-21 B+
SCPH scPharmaceuticals Inc. Q3 2023 2023-11-08 B
CMG Chipotle Mexican Grill, Inc. Q3 2023 2023-10-27 B+
TGLS Tecnoglass Inc. Q2 2023 2023-08-08 A
ET Energy Transfer LP Q2 2023 2023-08-02 C+
NMR Nomura Holdings, Inc. Q1 2024 2023-08-02 D
CTO CTO Realty Growth, Inc. Q2 2023 2023-07-28 B
IMAX IMAX Corporation Q2 2023 2023-07-26 B+
DAL Delta Air Lines, Inc. Q2 2023 2023-07-13 A
FTHM Fathom Holdings, Inc. Q1 2023 2023-05-10 C
BXSL Blackstone Secured Lending Fund Q1 2023 2023-05-10 A
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
TACT TransAct Technologies Incorporated Q4 2022 2023-03-08 A
VRE Veris Residential, Inc. Q4 2022 2023-02-22 D
ADPT Adaptive Biotechnologies Corporation Q4 2022 2023-02-14 C+
PI Impinj, Inc. Q4 2022 2023-02-08 B+
CNA CNA Financial Corporation Q4 2022 2023-02-06 B
UAL United Airlines Holdings, Inc. Q4 2022 2023-01-18 B
SIBN SI-BONE, Inc. Q3 2022 2022-11-07 C+
CHUY Chuy's Holdings, Inc. Q3 2022 2022-11-05 C+
SBGI Sinclair Broadcast Group, Inc. Q3 2022 2022-11-02 C
YMM Full Truck Alliance Co. Ltd. Q2 2022 2022-08-25 C+
ASTS AST SpaceMobile, Inc. Q2 2022 2022-08-15 D
TMCI Treace Medical Concepts, Inc. Q2 2022 2022-08-13 B+
WD Walker & Dunlop, Inc. Q2 2022 2022-08-09 C+
DM Desktop Metal, Inc. Q2 2022 2022-08-08 F
FLR Fluor Corporation Q2 2022 2022-08-05 D
XHR Xenia Hotels & Resorts, Inc. Q2 2022 2022-08-05 A
CRL Charles River Laboratories International Q2 2022 2022-08-03 C
IT Gartner, Inc. Q2 2022 2022-08-02 A
BRKL Brookline Bancorp, Inc. Q2 2022 2022-07-30 B+
INVH Invitation Homes Inc. Q2 2022 2022-07-28 B+
CME CME Group Inc. Q2 2022 2022-07-27 B
JBHT J.B. Hunt Transport Services, Inc. Q2 2022 2022-07-19 C+
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
ZVIA Zevia PBC Q1 2022 2022-05-12 B
VNRX VolitionRx Limited Q1 2022 2022-05-12 F
WHF WhiteHorse Finance, Inc. Q1 2022 2022-05-10 B+
HLIO Helios Technologies, Inc. Q1 2022 2022-05-10 C
BFIN BankFinancial Corporation Q1 2022 2022-05-06 A
CCRN Cross Country Healthcare, Inc. Q1 2022 2022-05-04 B
BXP Boston Properties, Inc. Q1 2022 2022-05-03 A
WRB W. R. Berkley Corporation Q1 2022 2022-04-26 B
FAT FAT Brands Inc. Q4 2021 2022-03-21 F
SOPH SOPHiA GENETICS SA Q4 2021 2022-03-15 C
HROW Harrow Health, Inc. Q4 2021 2022-03-10 C
NGVT Ingevity Corporation Q4 2021 2022-02-25 B
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D
GTES Gates Industrial Corporation plc Q4 2021 2022-02-07 C+
EXP Eagle Materials Inc. Q3 2022 2022-01-27 B
OOMA Ooma, Inc. Q3 2022 2021-12-02 B+
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
RNW ReNew Energy Global Plc Q2 2022 2021-11-18 C
LOW Lowe's Companies, Inc. Q3 2021 2021-11-17 B+
KTB Kontoor Brands, Inc. Q3 2021 2021-11-04 A
SXC SunCoke Energy, Inc. Q3 2021 2021-11-01 A
ASAN Asana, Inc. Q2 2022 2021-09-01 B+
TJX The TJX Companies, Inc. Q2 2021 2021-08-18 C
OWL Blue Owl Capital Inc. Q2 2021 2021-08-10 B+
AMC AMC Entertainment Holdings, Inc. Q2 2021 2021-08-09 D
GNK Genco Shipping & Trading Limited Q2 2021 2021-08-07 A
EMR Emerson Electric Co. Q3 2021 2021-08-04 B+
ESRT Empire State Realty Trust, Inc. Q2 2021 2021-07-29 C+
UMH UMH Properties, Inc. Q3 2018 2018-11-02 C+
CUBI Customers Bancorp, Inc. Q3 2018 2018-10-26 C+
ROP Roper Technologies, Inc. Q2 2018 2018-07-26 A
CP Canadian Pacific Railway Limited Q2 2018 2018-07-19 B+
LAUR Laureate Education, Inc. Q1 2018 2018-05-13 B+
FSS Federal Signal Corporation Q1 2018 2018-05-12 A
ILMN Illumina, Inc. Q1 2018 2018-04-24 A
HOLX Hologic, Inc. Q4 2017 2017-11-08 D
LIND Lindblad Expeditions Holdings, Inc. Q2 2017 2017-08-06 C
FLEX Flex Ltd. Q1 2018 2017-07-28 F
BIIB Biogen Inc. Q2 2017 2017-07-25 B
IONS Ionis Pharmaceuticals, Inc. Q1 2017 2017-05-09 C
ICFI ICF International, Inc. Q1 2017 2017-05-06 B+
BLKB Blackbaud, Inc. Q1 2017 2017-05-02 B+
SHOO Steven Madden, Ltd. Q1 2017 2017-04-21 C
ABR Arbor Realty Trust, Inc. Q4 2016 2017-03-03 B+
EVBN Evans Bancorp, Inc. Q4 2016 2017-02-06 B+
PRI Primerica, Inc. Q3 2016 2016-11-10 B+
NDSN Nordson Corporation Q3 2016 2016-08-23 A
NWSA News Corporation Q2 2016 2016-08-08 C+
GEO The GEO Group, Inc. Q2 2016 2016-08-02 B+
GES Guess?, Inc. Q1 2017 2016-05-25 F
ARKR Ark Restaurants Corp. Q1 2016 2016-05-13 B
GOGO Gogo Inc. Q1 2016 2016-05-06 C+
ESE ESCO Technologies Inc. Q2 2016 2016-05-03 A
RCL Royal Caribbean Cruises Ltd. Q1 2016 2016-04-29 C+
CAL Caleres, Inc. Q4 2015 2016-03-15 C+
HPP Hudson Pacific Properties, Inc. Q4 2015 2016-02-25 C
SAN Banco Santander, S.A. Q4 2015 2016-01-27 B

How the model reasoned

GES · Q1 2017 → YESThe question is about whether management conveys that the business's positive momentum has continued or strengthened beyond the period being reported, tied to a named, already-live driver. YES Management describes continued strength in Europe retail comps into Q2 ("up in the low double digits... maintaining the strong momentum we have seen since the second half of last year") and ties it to a specific, live driver: improved traffic and conversion rates. The wholesale order book also finished up 3%, confirming 3% growth in orders already placed. Product improvements are explicitly named as the underlying driver ("we are having a more comprehensive collection... improve our comps by generating more traffic... improve the product that we are offering"). This meets both criteria for continuation beyond the reported period tied to a named live driver.
ILMN · Q1 2018 → YESThe question is about whether management conveys that the business's positive momentum has continued or strengthened beyond the reported period, tied to a named, already-live driver. YES Management describes the sequencing consumables business as having "very exciting" trajectory and "tremendous momentum" that is "still in place" into the rest of 2018, explicitly tied to observed drivers already generating revenue in Q1 (NovaSeq, NextSeq, microarray, consumer genomics, oncology) and 2018 activity such as "approaching 100 orders" for iSeq and "growing interest" in single-cell research. They raise guidance based on these continuing trends rather than forecasts alone, confirming the strength has extended past the reported period through live business activity.
WRB · Q1 2022 → YESThe question is: Does management convey that the business's positive momentum HAS CONTINUED OR STRENGTHENED BEYOND THE PERIOD BEING REPORTED, and tie that to at least one NAMED, ALREADY-LIVE driver? ...NO The transcript shows management expressing confidence in Q1 momentum (especially March and later-quarter submissions in specialty/E&S) and noting that "every day that we are writing business in 2022 that goes by" is positive, but this is framed as ongoing daily activity within the current year rather than observed strength beyond the 2022 Q1 close. The call is April 25, 2022, so any post-quarter commentary is limited to general market trajectory comments without specific post-period-end activity metrics.

More from the question bank

Young streak off a low baseSecond demand front open and fundedSold out of itselfSomeone else's clock has started running agaThe hard part is already doneReality beat their plan and they're leaning All questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.